Dexamethasone 1.5 Mg
Generic Name: dexamethasone 1.5 mg
Brand Names:
Dexamethasone 1.5 Mg
DESCRIPTION Dexamethasone Tablets USP, 1.5 mg Each tablet contains: Dexamethasone USP, 1.5 mg. For oral administration.
Overview
DESCRIPTION Dexamethasone Tablets USP, 1.5 mg Each tablet contains: Dexamethasone USP, 1.5 mg. For oral administration.
Uses
INDICATIONS AND USAGE Allergic States: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. Dermatologic Diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome).
Dosage
DOSAGE AND ADMINISTRATION For Oral Administration The initial dosage varies from 0.75 to 9 mg a day depending on the disease being treated. It Should Be Emphasized That Dosage Requirements Are Variable And Must Be Individualized On The Basis Of The Disease Under Treatment And The Response Of The Patient. After a favorable response is noted, the proper maintenance dosage should be determined by decreasing the initial drug dosage in small decrements at appropriate time intervals until the lowest dosage that maintains an adequate clinical response is reached.
Side Effects
ADVERSE REACTIONS (listed alphabetically, under each subsection) The following adverse reactions have been reported with dexamethasone or other corticosteroids: Allergic Reactions: Anaphylactoid reaction, anaphylaxis, angioedema. Cardiovascular: Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction (see WARNINGS: Cardio-Renal ), edema, pulmonary edema, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis.
Interactions
Drug Interactions Aminoglutethimide: Aminoglutethimide may diminish adrenal suppression by corticosteroids. Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia. In addition, there have been cases reported in which concomitant use of amphotericin B and hydrocortisone was followed by cardiac enlargement and congestive heart failure. Antibiotics: Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance (see Drug Interactions: Hepatic Enzyme Inducers, Inhibitors and Substrates ).
Warnings
WARNINGS General Rare instances of anaphylactoid reactions have occurred in patients receiving corticosteroid therapy (see ADVERSE REACTIONS ). Increased dosage of rapidly acting corticosteroids is indicated in patients on corticosteroid therapy subjected to any unusual stress before, during, and after the stressful situation. Immunosuppression and Increased Risk of Infection Corticosteroids, including dexamethasone, suppress the immune system and increase the risk of infection with any pathogen, including viral, bacterial, fungal, protozoan, or helminthic pathogens. CONTRAINDICATIONS Systemic fungal infections (see WARNINGS: Infections: Fungal Infections ). Dexamethasone tablets are contraindicated in patients who are hypersensitive to any components of this product.
Pregnancy
Pregnancy Teratogenic Effects: Pregnancy Category C. Corticosteroids have been shown to be teratogenic in many species when given in doses equivalent to the human dose. Animal studies in which corticosteroids have been given to pregnant mice, rats, and rabbits have yielded an increased incidence of cleft palate in the offspring.There are no adequate and well-controlled studies in pregnant women. Corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Storage
Store and Despense Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture. Dispense in a well-closed, light-resistant container as defined in the USP/NF. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Distributed by: Larken Laboratories, Inc. Canton, MS 39046 www.larkenlabs.com Rev. 12/2022
Frequently Asked Questions
What is Dexamethasone 1.5 Mg used for?▼
INDICATIONS AND USAGE Allergic States: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. Dermatologic Diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome).
What are the side effects of Dexamethasone 1.5 Mg?▼
ADVERSE REACTIONS (listed alphabetically, under each subsection) The following adverse reactions have been reported with dexamethasone or other corticosteroids: Allergic Reactions: Anaphylactoid reaction, anaphylaxis, angioedema. Cardiovascular: Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction (see WARNINGS: Cardio-Renal ), edema, pulmonary edema, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis.
Can I take Dexamethasone 1.5 Mg during pregnancy?▼
Pregnancy Teratogenic Effects: Pregnancy Category C. Corticosteroids have been shown to be teratogenic in many species when given in doses equivalent to the human dose. Animal studies in which corticosteroids have been given to pregnant mice, rats, and rabbits have yielded an increased incidence of cleft palate in the offspring.There are no adequate and well-controlled studies in pregnant women. Corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
What are the important warnings for Dexamethasone 1.5 Mg?▼
WARNINGS General Rare instances of anaphylactoid reactions have occurred in patients receiving corticosteroid therapy (see ADVERSE REACTIONS ). Increased dosage of rapidly acting corticosteroids is indicated in patients on corticosteroid therapy subjected to any unusual stress before, during, and after the stressful situation. Immunosuppression and Increased Risk of Infection Corticosteroids, including dexamethasone, suppress the immune system and increase the risk of infection with any pathogen, including viral, bacterial, fungal, protozoan, or helminthic pathogens. CONTRAINDICATIONS Systemic fungal infections (see WARNINGS: Infections: Fungal Infections ). Dexamethasone tablets are contraindicated in patients who are hypersensitive to any components of this product.
Related Medications
Arnica Montana, Chamomilla, Echinacea (angustifolia), Boron Citrate, Symphytum Officinale, Calcarea Fluorica, Calcarea Phosphorica, Hekla Lava, Lycopodium Clavatum, Silicea, Calcarea Carbonica
arnica montana, chamomilla, echinacea (angustifolia), boron citrate, symphytum officinale, calcarea fluorica, calcarea phosphorica, hekla lava, lycopodium clavatum, silicea, calcarea carbonica
INDICATIONS: For temporary relief of tickling cough troublesome at night, pains in joints & bones, cramps in calves and soles.
Desonide Ointment, 0.05%
desonide ointment, 0.05%
Corticosteroid [EPC]
DESCRIPTION Desonide Ointment, 0.05% contains desonide (Pregna-1,4-diene-3,20-dione,11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-,(11ß,16α)) a synthetic corticosteroid for topical dermatologic use. The corticosteroids constitute a class of primary synthetic steroids used topically as anti-inflammatory and antipruritic agents. Chemically, desonide, the active ingredient in Desonide Ointment, 0.05% is C 24 H 32 O 6 .
Arnica Montana Root, Activated Charcoal, Potassium Carbonate, Lachesis Muta Venom, Nerium Oleander Leaf, Tobacco Leaf, Peumus Boldus Leaf, And Selenicereus Grandiflorus Whole
arnica montana root, activated charcoal, potassium carbonate, lachesis muta venom, nerium oleander leaf, tobacco leaf, peumus boldus leaf, and selenicereus grandiflorus whole
Non-Standardized Plant Allergenic Extract [EPC]
For occasional tiredness often experienced by the elderly. Application of this homeopathic remedy for the designated usage is exclusively based on homeopathic experience. With severe forms of this disease, a clinically proven therapy is indicated.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.